FDA to Approve New Generics, But Health Care Savings Will Be Minimal
Monday, December 5, 2011 - 08:02
in Health & Medicine
In 1984 the Hatch-Waxman Act made it cheaper and easier to put generic versions of a drug on the market. As a result of the expedited approval process, generics now make up more than 60 percent of prescription drugs sold in the U.S. and have saved the health care system $734 billion between 1999 and 2008 alone. [More]
